_id
691c3b471d3bbaa0018aba3a
Ticker
BCHMY
Name
Bachem Holding AG
Exchange
PINK
Address
Hauptstrasse 144, Bubendorf, Switzerland, 4416
Country
USA
Sector
Basic Materials
Industry
Chemicals
Currency
USD
Website
https://www.bachem.com
Description
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
Last Close
8.125
Volume
119
Current Price
8.125
Change
0.26
Last Updated
2026-01-20T16:19:10.362Z
Image
https://logo.clearbit.com/www.bachem.com
Ipo Date
-
Market Cap
6091957760
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.997
Sentiment Sources
1
Current Quarter
2022-12-31
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
749779400
Income Tax Expense
3824500
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
31451000
Short Term Investments
236976000
Receivables
179259000
Inventories
308046000
Total Current Assets
760420000
Property Plant Equipment
599790000
Total Assets
1383869000
Payables
32071000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
214208000
Equity
1169661000
Bs_currency_symbol
USD
Depreciation
7052500
Change In Working Capital
-
Cash From Operations
20980000
Capital Expenditures
35349000
Cash From Investing
-21486000
Cash From Financing
-822500
Net Change In Cash
-1526500
Cf_currency_symbol
USD
PE
36.9318
PB
0.5121011558049726
ROE
-
ROA
-
FCF
-14369000
Fcf Percent
-
Piotroski FScore
1
Health Score
60
Deep Value Investing Score
5.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
1
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
7
Quarters > 0 > quarter
2022-12-31
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
73721200
Quarters > 0 > income Statement > income Tax Expense
3824500
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
31451000
Quarters > 0 > balance Sheet > short Term Investments
236976000
Quarters > 0 > balance Sheet > receivables
179259000
Quarters > 0 > balance Sheet > inventories
308046000
Quarters > 0 > balance Sheet > total Current Assets
760420000
Quarters > 0 > balance Sheet > property Plant Equipment
599790000
Quarters > 0 > balance Sheet > total Assets
1383869000
Quarters > 0 > balance Sheet > payables
32071000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
214208000
Quarters > 0 > balance Sheet > equity
1169661000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
32035000
Quarters > 0 > cash Flow > depreciation
7052500
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
20980000
Quarters > 0 > cash Flow > capital Expenditures
35349000
Quarters > 0 > cash Flow > cash From Investing
-21486000
Quarters > 0 > cash Flow > cash From Financing
-822500
Quarters > 0 > cash Flow > net Change In Cash
-1526500
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0.5121011558049726
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-14369000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
60
Quarters > 1 > quarter
2022-09-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
3824500
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
179259000
Quarters > 1 > balance Sheet > inventories
308046000
Quarters > 1 > balance Sheet > total Current Assets
760420000
Quarters > 1 > balance Sheet > property Plant Equipment
599790000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
32071000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
164780000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
32035000
Quarters > 1 > cash Flow > depreciation
7052500
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
20980000
Quarters > 1 > cash Flow > capital Expenditures
35349000
Quarters > 1 > cash Flow > cash From Investing
-21486000
Quarters > 1 > cash Flow > cash From Financing
-822500
Quarters > 1 > cash Flow > net Change In Cash
-1526500
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-14369000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
46
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
605259000
Annuals > 0 > income Statement > cost Of Revenue
422704000
Annuals > 0 > income Statement > gross Profit
182555000
Annuals > 0 > income Statement > operating Expenses
472211000
Annuals > 0 > income Statement > operating Income
133048000
Annuals > 0 > income Statement > interest Expense
50000
Annuals > 0 > income Statement > pretax Income
135209000
Annuals > 0 > income Statement > net Income
120248000
Annuals > 0 > income Statement > eps
1.6039077471339827
Annuals > 0 > income Statement > dividends Per Share
59990000
Annuals > 0 > income Statement > shares Outstanding
74971893
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
21.981994485005593
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
95197000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
240489000
Annuals > 0 > balance Sheet > inventories
450163000
Annuals > 0 > balance Sheet > total Current Assets
822792000
Annuals > 0 > balance Sheet > property Plant Equipment
1063292000
Annuals > 0 > balance Sheet > total Assets
1922971000
Annuals > 0 > balance Sheet > payables
72926000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
531882000
Annuals > 0 > balance Sheet > equity
1391089000
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
120248000
Annuals > 0 > cash Flow > depreciation
43262000
Annuals > 0 > cash Flow > change In Working Capital
-64181000
Annuals > 0 > cash Flow > cash From Operations
146322000
Annuals > 0 > cash Flow > capital Expenditures
284618000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-62528000
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
1.6039077471339827
Annuals > 0 > ratios > PB
0.4378919182201858
Annuals > 0 > ratios > ROE
8.644162954347276
Annuals > 0 > ratios > ROA
6.253240428482801
Annuals > 0 > ratios > FCF
-138296000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-0.2284906131094292
Annuals > 0 > health Score
63
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
577316000
Annuals > 1 > income Statement > cost Of Revenue
400353000
Annuals > 1 > income Statement > gross Profit
176963000
Annuals > 1 > income Statement > operating Expenses
447936000
Annuals > 1 > income Statement > operating Income
129380000
Annuals > 1 > income Statement > interest Expense
31000
Annuals > 1 > income Statement > pretax Income
124208000
Annuals > 1 > income Statement > net Income
111859000
Annuals > 1 > income Statement > eps
1.4920262714215593
Annuals > 1 > income Statement > dividends Per Share
56236000
Annuals > 1 > income Statement > shares Outstanding
74971200
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
22.410603551607785
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
157725000
Annuals > 1 > balance Sheet > short Term Investments
140802000
Annuals > 1 > balance Sheet > receivables
176103000
Annuals > 1 > balance Sheet > inventories
340988000
Annuals > 1 > balance Sheet > total Current Assets
841531000
Annuals > 1 > balance Sheet > property Plant Equipment
814552000
Annuals > 1 > balance Sheet > total Assets
1682880000
Annuals > 1 > balance Sheet > payables
29089000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
362357000
Annuals > 1 > balance Sheet > equity
1320523000
Annuals > 1 > balance Sheet > currency_symbol
CHF
Annuals > 1 > cash Flow > net Income
111859000
Annuals > 1 > cash Flow > depreciation
37356000
Annuals > 1 > cash Flow > change In Working Capital
-63156000
Annuals > 1 > cash Flow > cash From Operations
249864000
Annuals > 1 > cash Flow > capital Expenditures
268402000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
126274000
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
1.4920262714215593
Annuals > 1 > ratios > PB
0.4612876867725894
Annuals > 1 > ratios > ROE
8.470810428898247
Annuals > 1 > ratios > ROA
6.646879159536033
Annuals > 1 > ratios > FCF
-18538000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-0.032110663830553804
Annuals > 1 > health Score
63
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
531741000
Annuals > 2 > income Statement > cost Of Revenue
360462000
Annuals > 2 > income Statement > gross Profit
171279000
Annuals > 2 > income Statement > operating Expenses
404517000
Annuals > 2 > income Statement > operating Income
127224000
Annuals > 2 > income Statement > interest Expense
74000
Annuals > 2 > income Statement > pretax Income
112074000
Annuals > 2 > income Statement > net Income
100684000
Annuals > 2 > income Statement > eps
1.3657401127491142
Annuals > 2 > income Statement > dividends Per Share
51620000
Annuals > 2 > income Statement > shares Outstanding
73721200
Annuals > 2 > income Statement > income Tax Expense
11390000
Annuals > 2 > income Statement > EBITDA
145466000
Annuals > 2 > income Statement > operating Margin
23.92593386629957
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
31451000
Annuals > 2 > balance Sheet > short Term Investments
236976000
Annuals > 2 > balance Sheet > receivables
171042000
Annuals > 2 > balance Sheet > inventories
308046000
Annuals > 2 > balance Sheet > total Current Assets
760420000
Annuals > 2 > balance Sheet > property Plant Equipment
599790000
Annuals > 2 > balance Sheet > total Assets
1383869000
Annuals > 2 > balance Sheet > payables
32071000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
214208000
Annuals > 2 > balance Sheet > equity
1169661000
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
100684000
Annuals > 2 > cash Flow > depreciation
29854000
Annuals > 2 > cash Flow > change In Working Capital
-67918000
Annuals > 2 > cash Flow > cash From Operations
92648000
Annuals > 2 > cash Flow > capital Expenditures
138458000
Annuals > 2 > cash Flow > cash From Investing
-63151000
Annuals > 2 > cash Flow > cash From Financing
-87006000
Annuals > 2 > cash Flow > net Change In Cash
-57740000
Annuals > 2 > cash Flow > currency_symbol
CHF
Annuals > 2 > ratios > PE
1.3657401127491142
Annuals > 2 > ratios > PB
0.5121011558049726
Annuals > 2 > ratios > ROE
8.607964187914275
Annuals > 2 > ratios > ROA
7.27554414471312
Annuals > 2 > ratios > FCF
-45810000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
-0.08615096447330561
Annuals > 2 > health Score
64
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
503234000
Annuals > 3 > income Statement > cost Of Revenue
336506000
Annuals > 3 > income Statement > gross Profit
166728000
Annuals > 3 > income Statement > operating Expenses
374307000
Annuals > 3 > income Statement > operating Income
128927000
Annuals > 3 > income Statement > interest Expense
365000
Annuals > 3 > income Statement > pretax Income
131386000
Annuals > 3 > income Statement > net Income
114682000
Annuals > 3 > income Statement > eps
1.5553534017167856
Annuals > 3 > income Statement > dividends Per Share
20490000
Annuals > 3 > income Statement > shares Outstanding
73733725
Annuals > 3 > income Statement > income Tax Expense
16704000
Annuals > 3 > income Statement > EBITDA
160174000
Annuals > 3 > income Statement > operating Margin
25.619691833222713
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
89191000
Annuals > 3 > balance Sheet > short Term Investments
353165000
Annuals > 3 > balance Sheet > receivables
106492000
Annuals > 3 > balance Sheet > inventories
272350000
Annuals > 3 > balance Sheet > total Current Assets
833671000
Annuals > 3 > balance Sheet > property Plant Equipment
445718000
Annuals > 3 > balance Sheet > total Assets
1298496000
Annuals > 3 > balance Sheet > payables
25030000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
177498000
Annuals > 3 > balance Sheet > equity
1120998000
Annuals > 3 > balance Sheet > currency_symbol
CHF
Annuals > 3 > cash Flow > net Income
114700000
Annuals > 3 > cash Flow > depreciation
25242000
Annuals > 3 > cash Flow > change In Working Capital
-43491000
Annuals > 3 > cash Flow > cash From Operations
97555000
Annuals > 3 > cash Flow > capital Expenditures
114554000
Annuals > 3 > cash Flow > cash From Investing
-469124000
Annuals > 3 > cash Flow > cash From Financing
437183000
Annuals > 3 > cash Flow > net Change In Cash
65695000
Annuals > 3 > cash Flow > currency_symbol
CHF
Annuals > 3 > ratios > PE
1.5553534017167856
Annuals > 3 > ratios > PB
0.5344224660748725
Annuals > 3 > ratios > ROE
10.230348314626788
Annuals > 3 > ratios > ROA
8.831910148356252
Annuals > 3 > ratios > FCF
-16999000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.033779514102783195
Annuals > 3 > health Score
67
Valuation > metrics > PE
36.9318
Valuation > metrics > PB
0.5121011558049726
Valuation > final Score
55.681839999999994
Valuation > verdict
0.5% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.1831368234043881
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
23.710517289763338
Liquidity > metrics > Quick Ratio
14.105391163356304
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
50
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
50
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
100
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-20T23:11:55.696Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABachem (BCHMY) Advances Building K, Acquires Vista Property; $250M Capacity Plan, GMP 2025 Stock Titan
Read more →(Last Updated 2022-12-31)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Bachem Holding AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2022-12-31)
(Last Updated 2022-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2022-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2022-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.